实用医学杂志 ›› 2020, Vol. 36 ›› Issue (23): 3283-3287.doi: 10.3969/j.issn.1006⁃5725.2020.23.024

• 调查研究 • 上一篇    下一篇

常用宫内节育器不良事件发生情况的趋势研究

周健,王冠融,林洁,施雯慧,杨月华,巴磊,孙志明   

  1. 江苏省计划生育科学技术研究所,国家卫生健康委计划生育药具不良反应监测中心(南京210036)
  • 出版日期:2020-12-10 发布日期:2020-12-23
  • 通讯作者: 孙志明E⁃mail:109616029@qq.com
  • 基金资助:

    江苏省卫生健康委科研课题(编号:H2018095);江苏省妇幼健康重点人才项目(编号:FRC201756);江苏省青年医学重点人才项目(编号:QNRC2016556);江苏省妇幼健康重点学科项目(编号:FXK201755);江苏省科技厅自主科研经费项目(编号:BM2018033⁃2);国家卫生健康委委托任务“避孕药具不良反应监测”项目

Research on the incidence of adverse events of common intrauterine device

  1. Jiangsu Institute of Planned Parenthood Research,NHC Contraceptives Adverse Reaction Surveillance Center,Nanjing 210036,China
  • Online:2020-12-10 Published:2020-12-23
  • Contact: SUN Zhiming E⁃mail:109616029@qq.com

摘要:

目的 分析常用宫内节育器(intrauterine device,IUD)不良事件发生情况,为合理使用IUD、促进避孕安全提供科学依据。方法 对2011-2019 年收集的IUD 不良事件报告数据库和IUD 人群使用信息数据库进行记录联接,计算10 种常用IUD 不良事件发生粗率,并比较其发生风险。结果 放置IUD后第1年,10种常用IUD不良事件的平均发生粗率为2.66%,随着使用时间的延长,IUD(活性γ型除外)不良事件发生粗率有逐渐下降的趋势。活性γ型却随着使用时间延长,不良事件发生粗率逐渐升高。宫铜200 型IUD 不良事件3 年和5 年累计发生粗率均列10 种IUD 之首,显著高于平均发生粗率,相对危险度(RR)分别为1.69(95%CI:1.55 ~ 1.83)和1.84(95%CI:1.72 ~ 1.98)。MLCu375 不良事件3 年和5 年累计发生粗率居第2 位,发生粗率亦均高于平均发生粗率,RR 分别为1.20(95%CI:1.12 ~ 1.28)和1.14(95%CI:1.07 ~ 1.21)。结论 建议应进一步加强避孕药具不良事件监测,提高报告数量和质量,减少漏报。对不良事件发生风险较高IUD品种应适当减少采购和使用数量。做好置器后定期随访和及时处理,重点关注置器后两年内以及临近放置年限的IUD使用状况,从而减少因症取出,促进避孕安全。

关键词: 宫内节育器, 不良事件, 发生率

Abstract:

Objective To protect contraceptive safety,analyze the adverse events of commonly used intra⁃uterine devices(IUD). Methods IUD adverse event reports were collected from 2011 to 2019 and populationinformation of using IUD database were linked to calculate the incidence rate of 10 common IUD adverse eventsand compare the risk. Results In the first year after IUD placement,the average incidence of adverse events of10 common IUD was 2.66%. With the prolongation of use time,the incidence of adverse events of IUD(exceptactive γ type)decreased gradually. However,the incidence of active γ type increased gradually. The cumulativeincidence of IUD in 3 and 5 years was 11.70% and 19.96% respectively,which was significantly higher thanthe average incidence. The relative risk(RR)was 1.69(95%CI:1.55 ~ 1.83)and 1.84(95%CI:1.72 ~ 1.98),respectively. The cumulative incidence of adverse events in 3 and 5 years of MLCu375 ranked the second place,8.30% and 12.33% respectively,and the incidence was also higher than the average incidence,RR was 1.20(95%CI:1.12 ~ 1.28)and 1.14(95%CI:1.07 ~ 1.21),respectively. Conclusion It is suggested that we should furtherstrengthen the monitoring of adverse events of contraceptives,improve the quantity and quality of reporting,andreduce the underreporting. The number of IUD varieties with high risk of adverse events shall be appropriatelyreduced. Regular follow⁃up and timely treatment shall be carried out after the IUD is placed,and the use of IUDwithin two years after the device is placed and near the placing period shall be focused,so as to reduce thewithdrawal of the cause of disease and promote the contraceptive safety.

Key words: intrauterine device(IUD), adverse event(AE), incidence